Two-Year Outcomes of the Paul Glaucoma Implant for Treatment of Glaucoma

Purpose:

To determine 2-year efficacy of the PAUL Glaucoma Implant (PGI), a novel glaucoma tube shunt in patients with advanced glaucoma.

Participants:

Patients with glaucoma refractory to maximum medical therapy or previous failed glaucoma surgery.

Methods:

Retrospective review of all patients who had underwent PGI implantation in a single tertiary institution between May 1, 2017 and March 30, 2021.

Main Outcome Measures:

Primary outcome measure was failure defined as intraocular pressure (IOP)>18 mm Hg or

Source: Journal of Glaucoma - June 1, 2022 Category: Opthalmology Tags: New Glaucoma Insights: Original Studies Source Type: research